Past webinar replays
Closing the Gap: Strategies for Resolving Imaging Discrepancies in Oncology Drug Trials
Imaging plays a critical role in assessing drug efficacy in clinical trials. However, variability in imaging interpretation can lead to discrepancies in the trial results, which can have significant implications.This webinar explores the challenges associated with site versus central image reading in oncology clinical trials, how they impact trial results, and their root for better […]
Decentralized Clinical Trials: The patient-centric future of oncology R&D?
Join Labcorp Drug Development and Median Technologies leaders in a stimulating conversation to learn how proven, modern, decentralized clinical trial (DCT) strategies will improve patient compliance and engagement, accelerate timelines, and decrease site burden.
Overcoming the challenges in deploying new imaging biomarkers in clinical trials – Perspectives from patients, physicians and other stakeholders
This webinar is jointly organized by Labcorp Drug Development and Median Technologies. New Imaging biomarkers have a strong potential to provide additional insight for clinical trials: better selection of patients, prediction of response to therapy, early assessments of drug effects and safety. However, implementing them in clinical trials often promote challenges. The aim of this webinar is to discuss these challenges from the perspective of patients, physicians and the different stakeholders involved in the oncology clinical trials. Want to know more? Register now!
Effective collaboration between imaging CRO and investigator sites contributes to successful clinical trials
Investigator sites have an instrumental role in clinical trials, with endless responsibilities such as recruiting patients, acquiring, and submitting medical images to imaging CROs. Imaging CROs such as Median Technologies, will collect and review medical images to assess drug safety and efficacy based on the imaging endpoints. Efficient communication and streamlined processes between investigator sites and imaging CROs are key success factors for clinical trials in oncology. Want to know more? Watch the replay now!
Discuss the 4 main causes of variability in centralized oncology radiological assessments
Inter-reader variability can create challenges in oncology trial results. During this 45-minute presentation, Median Technologies addresses the 4 main causes of variability occurring during RECIST1.1 assessment and describes control strategies using data analytics and medical investigations. Want to know more? Watch the video now!